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An Entirely Automatic Method to Score Crypt Loss and Infiltration from Pathology Slides in a Mouse DSS Model of Colitis

**Cleopatra Kozlowski, Jason deVoss, Joseph Beyer, Lauri Diehl**

Genentech, South San Francisco, CA. E-mail: <cleopatk@gene.com>

**CONTENT**

The DSS (dextran sodium sulfate) model of colitis is a mouse model of inflammatory bowel disease, a condition that affects more than 1 million people in the US alone. Microscopic symptoms include loss of crypt cells from the gut lining, and infiltration of inflammatory cells into the colon. An experienced pathologist requires over 6h for 100 H&E slides to manually score loss of crypts in selected regions of the mouse gut. In order to increase the efficiency of scoring, we devised an entirely automatic method to quantify loss of crypt cells in the whole slide.

**TECHNOLOGY**

We used Definiens Developer (Definiens AG, Munich, Germany) to design an image analysis algorithm.

**DESIGN**

The method relies on a combination of morphological and intensity based features of every tissue area, as well as a neighbor-based classification method. Further, we developed another entirely automatic method to count infiltrating macrophages, neutrophils, and T cells in IHC of serial sections to the H&E slides.

**RESULTS**

We found an overall correlation of \> 0.7 between independently assigned automatic and manual scores, in approximately 800 DSS treated mice. The correlations were robust across 12 studies, in spite of large variations in slide quality and staining intensity. Though the analysis requires approximately 40min of CPU time per slide, cluster computing allows us to analyze up to 500 slides overnight without any manual intervention.

**CONCLUSION**

Overall, our methods greatly facilitate the scoring of mouse colon in DSS induced colitis, and enable quantitative analysis of morphological tissue changes and cell infiltration.

A New Method for Analyzing Cellular Protein Patterns from Routine Histopathology Images

**Gustavo K. Rohde, Wei Wang, Cheng Chen, Dejan Slepcev, John A. Ozolek**

Carnegie Mellon University, Department: Biomedical Engineering, Pittsburgh, PA. E-mail: <gustavo.rohde@gmail.com>

**CONTENT**

We describe a new technology for analyzing the morphology of cells and subcellular structures from digital pathology image data. The new approach is substantially different from existing technology in that it allows for visualization and discovery of meaningful differences in subcellular protein patterns in normal vs. cancerous cells.

**TECHNOLOGY**

Following automated image segmentation, the differences between normal and cancerous cellular patterns are computed by transporting (morphing) one pattern into another. The morphing operation allows for the definition of a distance as well as a path from one structure to another \[[Figure 1](#F1){ref-type="fig"}\], to which all other structures can be compared. The differences between two sets of patterns can be found by computing the path that best separates them according to the standard p value. In contrast to standard numerical feature-based approaches, the method we describe allows for easy and meaningful visualization.
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**DESIGN**

We apply our methods to decoding differences between protein patterns (nuclear chromatin, as well as golgi protein patterns) in normal and cancerous cells. Groups of cells are then compared to elucidate the differences in structure that are present in the data. Nuclear chromatin patterns imaged using Feulgen staining from 10 thyroid cases (normal thyroid, follicular adenoma, follicular carcinoma), 5 liver cases (normal, fetal-type hepatoblastoma) and two proteins (giantin and gpp130) in the golgi apparatus of HeLa cells imaged with immunofluorescence. Patterns are first normalized for translation, rotation, as well as size (optional).

**RESULTS**

Results show that nuclear chromatin patterns in normal liver vs. hepatoblastoma differ, and that the most significant difference (in the sense of *p* value) is that normal cells tend to have chromatin more densely packed while cancerous cells tend to have a more disperse distribution ([Figure 1](#F1){ref-type="fig"}). Results describing differences between normal thyroid, follicular adenoma and carcinoma, as well as two golgi protein patterns in HeLa cells, will be shown.

**CONCLUSIONS**

The spatial distribution of cellular patterns can contain important biological and diagnostic information. The new method described is able to process the image data automatically with the end of facilitating visualization of important differences between normal vs. cancerous cells.
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DM96 for Peripheral Blood Differentials in a University Hematology/Oncology Center

**M. Rollins-Raval, Lydia Contis**

University of Pittsburgh Medical Center Division of Hematopathology, Pittsburgh, PA. E-mail: <rollinsravalma@upmc.edu>

**CONTENT**

Rapid, accurate peripheral blood differentials are essential to maintain standards of patient care. CellaVision^™^ DM96 (CellaVision AB, Lund, Sweden) (CV) is an automated digital morphology and informatics system used to locate, pre-classify, store and transmit platelet, red and white blood cell images to a trained technologist who confirms or edits CV cell classification. Efficiency of CV increases as the need to edit classification (i.e. technologist time) decreases. We assessed our experience with CV by evaluating both percentage of correct pre-classified cells out of CV initial classification (CPC/CVI) and percentage of correct pre-classified cells out of total number of verified cells for different cell classes (CPC/VC) in a university hospital with a large hematology/oncology patient population.

**TECHNOLOGY**

CellaVision^™^ DM96 (see Content).

**METHODS**

Using CV\'s Database Query Tool, Version 4.2 (CellaVision AB, Lund, Sweden), we analyzed classification accuracy of CV for white blood cells, erythroblasts, platelets and artefacts over six months.

**RESULTS**

The CV classified 211218 events. For all events, CPC/CVI and CPC/VC reached 94% and 93%, respectively. Values for segmented neutrophils, eosinophils, lymphocytes, monocytes, giant platelets, smudge cells and artefacts were \> 80% for both CPC/CVI and CPC/VC. CPC/CVI and CPC/VC were \< 80% for immature granulocytes (band neutrophil, promyelocyte, myelocyte and metamyelocytes) (differences usually within one stage of maturation) \[[Table 1](#T1){ref-type="table"}\].
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**CONCLUSIONS**

Reduced immature granulocyte classification accuracy may be due in part to the subjectivity in classification of these cells, length of experience with the system and individual expertise of the technologist. Cells with low CPC/CVI and CPC/VC comprised a minority of the cells and should not significantly affect the technologist re-classification time. CV serves as a clinically useful instrument in performance of peripheral blood differentials.

An Accuracy Validation Framework for Automated Pathology Image Segmentation and Classification Algorithms

**Jingjing Gao, Jun Kong, Fusheng Wang, Tahsin Kurc, Lance Waller^1^, Joel Saltz**

Emory University, Center for Comprehensive Informatics and ^1^Department of Biostatistics and Bioinformatics, Atlanta, GA. E-mail: <jgao@emory.edu>

**CONTENT**

A major challenge in digital pathology is the large inter-observer variability among pathologists. As pathology has largely been a qualitative discipline, significant disconcordance in human diagnosis is well observed. Consequently, computer-based methods have been developed to execute such tasks as nuclei segmentation and classification. Due to the large number of nuclei in pathology slides, the algorithm accuracy and precision validation are often lack of statistically theoretical support. In practice, researchers usually make visual assessments by overlaying the results on raw images. To address this problem, we designed a generic human-guided validation workflow both statistically defensible and reproducible.

**TECHNOLOGY**

To minimize the validation efforts required from human experts, statistical stratified sampling technique was adopted to select sub-regions from whole-slide pathology images. Sub-region images were clustered into strata by K-means analysis on imaging features. Sample size was calculated based on preliminary analysis. For human annotations, original images were pre-loaded to the Aperio image server to facilitate nuclei annotations by pathologists. Human markups were then transferred into a pre-setup Pathology Analytical Imaging Standards (PAIS) database with built-in query functions for spatial based measurements. Numerous distance- and region-based measurements along with the statistical agreement test were performed at sub-image and whole-slide level, making the algorithm validation process definitive.

**DESIGN**

We design the workflow as follows. First, a set of sub-images with pre-determined sizes were randomly selected from strata identified by the clustering analysis based on imaging features. Secondly, we applied a variety of algorithms to selected sub-images for nuclei segmentation and classification. Human expert markups were also captured through an image viewer (Aperio ImageScope Client), transformed into PAIS document format and then loaded into PAIS database. Finally, computer generated segmentations were compared to human annotations using distance-based, region-based metrics and statistical agreement indices.

**RESULTS**

To assure the scalability and generalizability of the proposed framework, four types of brain tumors, namely, glioblastoma, oligodendroglioma, oligoastrocytoma and astrocytomas with various grades, were included in the scope of tests. Four sub-regions were randomly selected from clusters stratified on imaging features for each slide. A total of 431 nuclei were segmented by a computationally efficient algorithm and an experienced neuropathologist. With the theory of survey sampling and the measures from stratified randomly sampled sub-regions, we estimated the means of three measures (overlapping-ratio, centroid-distance, and Hausdorff-distance) for each slide and provided a 95% confidence interval for each estimated mean. Our tests suggest that 95% of the time the mean of overlapping ratio for a selected slide is within the range (0.791, 0.802). This implies concordance between human and algorithm on nuclei segmentation.

**CONCLUSIONS**

We have proposed a design pattern for a representative use case from the biomedical and clinical research domain that aims at validating segmentation and classification algorithms for pathology images.

Design and Evaluation of a Virtual Reality Microscope

Darren Treanor, Rebecca Randell, Rhys Thomas, Roy Ruddle

University of Leeds, Pathology and Tumour Biology, Leeds, United Kingdom. E-mail: <darrentreanor@nhs.net>

**CONTENT**

We have been developing a virtual reality (VR) microscope that could be used for viewing digital slides for diagnostic work. Using existing systems, it can take up to 60% longer to perform diagnoses using digital slides than on the light microscope. Our goal is to develop a VR microscope that allows diagnoses to be made quicker, but as accurately as, a conventional microscope, an essential step in making digital pathology suitable for routine use. We are achieving this by combining ultra-high resolution displays with VR technology and ′intelligent navigation′ techniques.

**METHODS**

An iterative approach to development and evaluation is being taken. A first version of our VR microscope went through a phase of formative evaluation and the feedback from this was used to refine the software. We then evaluated the VR microscope using a mixed factorial experimental design with technology (2 levels, conventional microscope and VR microscope) and task (2 levels) as within-participant variables and grade of pathologist (2 levels) as a between-participant variable. We had 16 participants in the evaluation.

**RESULTS**

No significant difference in time taken to come to a diagnosis was found between the conventional microscope and VR microscope. We will also present findings regarding diagnostic confidence, diagnostic accuracy, pathologist preference, and navigation patterns in the two conditions.

Evaluation of Different Display Modalities for Whole Slide Images in Pathology

**Gaurav Sharma, Gautam Sharma, Abid Shah, Anil Parwani, Walid E. Khalbuss, Sara E. Monaco, Alka Palekar, Rajendra Singh, Liron Pantanowitz**

University of Pittsburgh Medical Center, Division of Pathology Informatics, Department of Pathology, Pittsburgh, PA. E-mail: <sharmag@med.umich.edu>

**CONTENT**

Diagnostic accuracy and user confidence at interpreting whole slide images (WSI) of digitized surgical pathology (SP) and cytopathology (CP) slides depends in part on the presentation and perception of WSI. The aim of this study was to compare the user experience with different display (computer monitor) modalities.

**TECHNOLOGY**

Laptop monitor - IBM Thinkpad 14.1 inch (LPTP), non-medical grade monitor - HP ZR24w 24 inch (NMGM), medical grade monitor (small) - Eizo FlexScan SX2462W 24 inch (MGM1), medical grade monitor (large) - Barco Coronis Fusion 6MP 30 inch (MGM2), optical microscope - Leica DM2000 (OM), WSI scanner (Aperio Scanscope XT), WSI browser (Aperio Imagescope 10.2), data storage - portable hard drive (Seagate Free Agent 1 TB).

**DESIGN**

Glass slides from 60 cases (30 SP, 30 CP) of varying difficulty were digitized. WSI stored on a portable hard drive were randomly reviewed on 4 different monitors under standard conditions and also examined with an OM by 6 pathologists with a washout period of 2 weeks. Each pathologist reviewed 30 slides based on their area of expertise. Data was captured on a graded scale (high, medium and low) for 8 parameters (see [table](#T2){ref-type="table"}).
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**RESULTS**

Results from 900 encounters (720 electronic and 180 OM over 3 months) are shown in the table.

Across SP and CP, the difference in image quality and diagnostic confidence was statistically significant (P\<0.001) between medical grade modalities (MGM1,2 and OM) compared to non-medical grade modalities (LPTP and NMGM). Monitor brightness was the most frequent (13.19%) screen adjustment.

**CONCLUSIONS**

Non-medical grade displays had inferior user experience compared to medical grade monitors and the light microscope. Although comparable to the microscope, limiting issues with MGM include pixilation and prolonged refresh lag. With advances in display technology, MGM would be the optimum modality to electronically display WSI.
